MPS Limited — PPTs, 21-07-2026: Investor Presentation

MPSLTD delivered a stellar Q1 FY27, reporting record revenue of **INR 224.24 Cr** (+20.38% YoY) and PAT soaring 42.99% to **INR 50.39 Cr**. EBITDA surged 53.03% to **INR 76.96 Cr**, marking their strongest Q1 ever. Research Solutions (ex-AJE) revenue grew 26.33% YoY, and Education Solutions jumped 42.21% YoY.

Growth was boosted by Unbound Medicine's first full quarter, significantly expanding their institutional customer base. Strategic focus areas include client diversification (841 clients billed in Q1 FY27) and AI implementation in Research workflows for productivity gains. Corporate Learning's EBITDA margin hit 25.33% due to restructuring benefits.

Key metrics: Revenue **INR 224.24 Cr**, EBITDA **INR 76.96 Cr** (34.32% margin), PAT **INR 50.39 Cr**, Basic EPS **INR 29.70**. Cash & equivalents stood at **INR 138.02 Cr** vs. borrowings of **INR 37.63 Cr**.

Management remains confident in its FY27 EBITDA guidance of **INR 300+ Cr**, expecting to comfortably clear this target given the strong Q1 performance and historical second-half outperformance.